Numbness is a common clinical problem with complex etiology and a lack of systematic clinical research data, affecting patients' physical and mental health and imposing an economic burden on society. This consensus was written by multidisciplinary experts including general practice, neurology, and geriatrics. By reviewing and integrating the cutting-edge domestic and international evidence-based medical research results in the field of numbness in recent years, it elaborates in detail on the definition, classification, epidemiology, etiology and pathogenesis, comprehensively summarizes the diagnostic methods of numbness, including detailed consultation, systematic physical examination, and auxiliary examination, and specifically expounds the individualized treatment principles and measures for numbness. The consensus also emphasizes the comprehensive community management of numbness, including screening, follow-up, comprehensive interventions, health education, multidisciplinary diagnostic support, and graded referral systems. Furthermore, it proposes future directions for the diagnosis, treatment, and management of numbness from the perspectives of clinical practice, education and training, and scientific research innovation. The ultimate aim is to provide guidance and support for the standardized diagnosis, treatment, and whole-process care of patients with numbness.
As the world's tenth most prevalent cancer, bladder cancer imposes a substantial burden in China, exacerbated by rapid demographic aging and high rates of smoking and occupational exposure. The 10th edition of the Australian Guidelines for Preventive Activities in General Practice does not recommend bladder cancer screening for asymptomatic adults. Primary care practitioners are uniquely positioned to spearhead this transition by prioritizing primary prevention and lifestyle counseling. By focusing on high-risk cohorts and integrating early detection with standardized management, China can more effectively utilize healthcare resources and mitigate the long-term impact of the disease.
Influenza is characterized by pronounced seasonality, rapid transmission, and a high risk of severe illness among high-risk populations. These features pose a substantial threat to public health. In primary healthcare settings, the substantial burden of influenza cases, combined with relatively limited diagnostic and therapeutic resources, creates a pressing need for standardized and actionable guidance. Historically, recommendations for influenza treatment and prophylaxis have largely relied on expert consensus in China, with a lack of systematic, evidence-based guidelines. In recent years, accumulating evidence on traditional antiviral agents such as neuraminidase inhibitors, as well as emerging agents targeting RNA polymerase, has expanded therapeutic options for influenza, underscoring the need to systematically update existing treatment recommendations. Accordingly, a multidisciplinary panel of Chinese experts developed the Clinical Practice Guidelines for the Treatment and Prophylaxis of Influenza in China (2025 Edition) following the Scientific, Transparent, and Applicable Rankings (STAR) framework. With primary healthcare institutions as the main application setting, this guideline focuses on antiviral therapy and prophylaxis, systematically summarizing and updating treatment indications, drug selection, dosing regimens, duration, and safety management across different populations. Specific recommendations are provided for key groups such as children and pregnant women. Indications and strategies for prophylaxis during seasonal epidemic peaks are defined. The guideline presents a total of 19 evidence-based recommendations, providing systemic and actionable guidance for the clinical management and prevention of influenza in primary healthcare settings.
Against the background of the increasingly younger onset of non-communicable diseases, physical inactivity has become an important and modifiable risk factor affecting the health of the working population. Although physical activity promotion has been consistently emphasized in national health policies in China, clearer and more operational pathways are still needed to systematically embed physical activity advice into routine general practice. This article focuses on the core concept of "embedding physical activity into daily life" proposed in the 10th edition of the Guidelines for Preventive Activities in General Practice issued by the Royal Australian College of General Practitioners (RACGP). Drawing on the World Health Organization guidelines on physical activity and sedentary behavior, as well as evidence from domestic and international literature, the paper interprets and discusses the role of general practitioners in physical activity promotion, key practice considerations, and potential implementation pathways. Experiences from community-based general practice in Shenzhen are also discussed to examine the contextual application and practical relevance of this concept in health management among the working population. This article aims to provide practical reference for promoting physical activity within general practice settings.
